US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

677.63

+30.764.75%

Number of Gainers:2

Number of Losers:1

Number of Flat:1

PE:- -

High:677.94

Open:644.93

Low:625.23

Close:646.87

Volume:31.08M

Turnover:767.38M

Market Cap:20.71B

Float Cap:15.39B

Loading ...

Beam Therapeutics President Giuseppe Ciaramella Disposes of Common Shares

Why Is CRISPR Therapeutics Stock Surging Thursday?

Tempus AI to Participate in Morgan Stanley Technology, Media & Telecom Conference

Recursion Pharmaceuticals Price Target Maintained With a $8.00/Share by Needham

Recursion Pharmaceuticals price target lowered to $6 from $7 at BofA

Is CRISPR Therapeutics (CRSP) Attractively Priced After Mixed Long Term Share Performance?

Simply Wall St.

Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million

Benzinga_recent_news

Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test

Simply Wall St.

Balanced Risk-Reward Keeps Recursion at Hold as Key Clinical Catalysts Remain Longer-Dated

Cathie Wood’s ARK Investment buys 213K shares of Tempus AI today

Tempus AI Inc. Files Initial Beneficial Ownership Statement for Thomas Edward Schoenherr, CEO of Diagnostics

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)

What's Behind The Jump In Recursion Pharmaceuticals Stock?

Tempus AI Shares Fall 2.4% After Q4 Results

THOMSON REUTERS

Tempus AI price target raised to $68 from $59 at Baird

Tempus AI Inc (Pre-Reincorporation) : Btig Cuts Target Price to $90 From $105

THOMSON REUTERS

Tempus AI price target lowered to $60 from $80 at JPMorgan

Tempus AI price target lowered to $70 from $76 at TD Cowen

Tempus AI Inc (Pre-Reincorporation) : Needham Cuts Target Price to $75 From $100

THOMSON REUTERS

Tempus AI Is Maintained at Buy by BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":677.627,"timestamp":1772139599999,"preClose":646.86945,"halted":0,"volume":31078200,"delay":0,"changeRate":0.047548,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":30.757568,"latestTime":"02-26 16:00:00 EST","open":644.92523,"high":677.9364,"low":625.23395,"amount":767384013.398859,"amplitude":0.081473,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.434027,"peRate":-12.842758,"turnoverRate":0.044578,"increases":2,"decrements":1,"flats":1,"marketCap":20713325440,"floatMarketCap":15393112448},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":677.9364,"amplitude":0.081473,"preClose":646.86945,"low":625.23395,"pbRate":"4.434027","latestPrice":677.627,"volume":31078200,"delay":0,"open":644.92523,"prevYearClose":658.3995,"prevWeekClose":644.5843,"prevMonthClose":653.7386,"prevQuarterClose":658.3995,"fiveDayClose":663.5246,"twentyDayClose":700.3596,"sixtyDayClose":745.511,"secType":"PLATE","market":"US","turnoverRate":0.044578,"peRate":-12.842758,"marketCap":20713325440,"floatMarketCap":15393112448,"timestamp":1772139599999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":2,"down":1,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614107696","title":"Beam Therapeutics President Giuseppe Ciaramella Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614107696","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614107696?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:08","pubTimestamp":1772140101,"startTime":"0","endTime":"0","summary":"Giuseppe Ciaramella, President of Beam Therapeutics Inc., reported a disposal of common shares of Beam Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL1Tv4gt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beam Therapeutics President Giuseppe Ciaramella Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1861559042.SGD","BK4505","LU1861558580.USD","BK4588","BK4535","BEAM","BK4585","BK4556","BK4611"],"gpt_icon":0},{"id":"2614020967","title":"Why Is CRISPR Therapeutics Stock Surging Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020967","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614020967?lang=en_us&edition=fundamental","pubTime":"2026-02-27 02:45","pubTimestamp":1772131500,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics AG  shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum for its lead gene therapy and a deepening pipeline.Casgevy, the gene-editing therapy for sickle cell disease and transfusion-dependent beta thalassemia, generated $54 million in the fourth quarter and $116 million for the full-year 2025. A total of 64 patients received infusions in the fourth quarter alone, with 147 initiating treatment through the first cell collection for the year — nearly triple 2024 levels.William Blair analyst Sami Corwin noted that “the increase to 147 first cell collections strengthens confidence that higher initiation volumes will translate into materially greater revenue in 2026.”Beyond hematology, the company continues to advanceits in vivo liver editing programs.Short interest rose from 21.89 million to 22.64 million shares, representing 26.45% of the float. At an average daily volume of 1.71 million shares, shorts would need roughly 13 day","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/26/Crispr-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/26/Crispr-Therapeutics.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50903172/why-is-crispr-therapeutics-stock-surging-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50903172/why-is-crispr-therapeutics-stock-surging-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4139","BK4556","BK4585","BK4588","BK4611","CRSP"],"gpt_icon":0},{"id":"2614042293","title":"Tempus AI to Participate in Morgan Stanley Technology, Media & Telecom Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614042293?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:31","pubTimestamp":1772112665,"startTime":"0","endTime":"0","summary":"ei=1753938&tp_key=e25fc24c17&tp_special=8, and a recording will be posted on Tempus’ Investor Relations Events page.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on February 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL5xVTW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1720051017.SGD","LU1363072403.SGD","BK4127","TEMT","LU1989772840.SGD","LU0882574139.USD","BK4611","LU0106261372.USD","LU1732800096.USD","LU1791710400.SGD","LU0912757837.SGD","LU2023251221.USD","LU2111349929.HKD","LU0320765646.SGD","LU0006306889.USD","BK4121","LU0528227936.USD","LU0557290698.USD","LU0098860793.USD","LU2347655156.SGD","LU1244550221.USD","LU1162221912.USD","IE00BZ1G4Q59.USD","LU0106831901.USD","LU0795875169.SGD","LU2133065610.SGD","LU0158827948.USD","LU0225283273.USD","LU2089283258.USD","LU2089284900.SGD","LU1989772923.USD","LU1074936037.SGD","LU1791710582.SGD","LU0267386448.USD","LU0314104364.USD","LU2271345857.HKD","BK4613","TEM","LU0971096721.USD","LU0158827781.USD","LU2028103732.USD","LU0234570918.USD","BK4504","BK4534","BK4588","LU0795875086.SGD","BK4516","LU1732799900.SGD","LU2357305700.SGD","LU1720051108.HKD","LU1244550494.USD","LU1244550577.SGD","BK4581","LU1861558580.USD","LU1548497426.USD","IE00BKVL7J92.USD","LU1861559042.SGD","LU1668664300.SGD"],"gpt_icon":1},{"id":"2614043895","title":"Recursion Pharmaceuticals Price Target Maintained With a $8.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043895","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614043895?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:35","pubTimestamp":1772105700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 06:35 ET (11:35 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4609","BK4611","BK4539","RXRX","BK4139"],"gpt_icon":0},{"id":"2614695043","title":"Recursion Pharmaceuticals price target lowered to $6 from $7 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2614695043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614695043?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:32","pubTimestamp":1772105527,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $6 from $7 and keeps a Neutral rating on the shares. The firm revised i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-price-target-lowered-to-6-from-7-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-price-target-lowered-to-6-from-7-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4548","BK4539","RXRX","BK4609","BK4139"],"gpt_icon":0},{"id":"2614110091","title":"Is CRISPR Therapeutics (CRSP) Attractively Priced After Mixed Long Term Share Performance?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614110091","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614110091?lang=en_us&edition=fundamental","pubTime":"2026-02-26 14:32","pubTimestamp":1772087537,"startTime":"0","endTime":"0","summary":"If you are wondering whether CRISPR Therapeutics at around US$55.20 a share looks like an opportunity or a stock to be cautious about, the key question is how its current price lines up with its underlying value.\nThe stock has recent returns of 3.1% over 7 days, 1.0% over 30 days, 2.7% year to date, 24.3% over 1 year and 15.7% over 3 years, while the 5 year return sits at a 53.6% decline. This gives a mixed picture of how sentiment has shifted over different timeframes.\nRecent attention on...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/is-crispr-therapeutics-crsp-attractively-priced-after-mixed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/is-crispr-therapeutics-crsp-attractively-priced-after-mixed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1861558580.USD","LU1861559042.SGD","CRSP","BK4556","BK4611","BK4139","DCF","BK4588"],"gpt_icon":0},{"id":"2614906286","title":"Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614906286","media":"Benzinga_recent_news","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614906286?lang=en_us&edition=fundamental","pubTime":"2026-02-26 10:20","pubTimestamp":1772072400,"startTime":"0","endTime":"0","summary":"On Wednesday, Feb. 25, 2026, Cathie Wood-led Ark Invest bought $11M in Tempus AI after a 7% drop","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Palantir--Teradyne--Caterpillar--NXP-Sem.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Palantir--Teradyne--Caterpillar--NXP-Sem.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/02/50876128/cathie-wood-is-buying-the-tempus-ai-dip-ark-snaps-up-stock-worth-11-million","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/02/50876128/cathie-wood-is-buying-the-tempus-ai-dip-ark-snaps-up-stock-worth-11-million","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4121","IE00BZ9MQY76.HKD","TEMT","LU2317271919.USD","IE00B894F039.SGD","IE00B19Z9Z06.USD","GB00BDT5M118.USD","BK4613","BK4544","BK4508","BK4548","BK4551","BK4534","LU1861558580.USD","LU1861559042.SGD","BK4611","LU0348723411.USD","TEM","PINS","BK4588","IE00B19Z9P08.USD","BK4585","BK4077"],"gpt_icon":1},{"id":"2614069058","title":"Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069058","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069058?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:36","pubTimestamp":1772069797,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) just posted its FY 2025 numbers with Q4 revenue of US$367.2 million, a basic EPS loss of US$0.30, and net income loss of US$54.2 million, setting the tone for how investors will read the rest of the year. The company reported revenue of US$200.7 million in Q4 2024 and US$367.2 million in Q4 2025, while quarterly basic EPS moved from a loss of US$0.07 to a loss of US$0.30 over the same period, so the key question now is how to weigh that top line against the still negative...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-loss-deepens-to-us030-eps-as-premium-valuation","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-loss-deepens-to-us030-eps-as-premium-valuation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","AIYY","BK4611","BK4588","BK4023","BK7095","TEM","BK4528","BK4121","BK4551","BK4613","LU1861558580.USD","BK4543","LU1861559042.SGD","BK4587","TEMT"],"gpt_icon":1},{"id":"2614069711","title":"Balanced Risk-Reward Keeps Recursion at Hold as Key Clinical Catalysts Remain Longer-Dated","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069711","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069711?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:25","pubTimestamp":1772069133,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan has reiterated their neutral stance on RXRX stock, giving a Hold rating yesterday. Alec Stranahan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-keeps-recursion-at-hold-as-key-clinical-catalysts-remain-longer-dated-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-keeps-recursion-at-hold-as-key-clinical-catalysts-remain-longer-dated-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00B1BXHZ80.USD","BK4548","BK4207","LU0417517546.SGD","LU1791807156.HKD","LU1162221912.USD","LU2265009873.SGD","LU0980610538.SGD","LU0053666078.USD","IE00B19Z3581.USD","LU0128525689.USD","BK4581","LU2129689431.USD","LU0306806265.USD","IE00BZ1G4Q59.USD","BK4553","LU1804176565.USD","LU1880398471.USD","LU1280957306.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU1496350502.SGD","LU1894683264.USD","LU2133065610.SGD","IE00BFXG1179.USD","LU1267930227.SGD","LU0106831901.USD","LU0070302665.USD","LU0130517989.USD","LU0130102774.USD","BK4609","BK4139","LU1894683348.USD","IE00B7SZLL34.SGD","BK4504","LU0971096721.USD","LU0648001328.SGD","LU0321505439.SGD","LU0211331839.USD","IE00B19Z3B42.SGD","LU0256863811.USD","LU0640476718.USD","LU0648000940.SGD","LU1668664300.SGD","IE0001KFT4U8.USD","LU1366192091.USD","LU0203347892.USD","LU0321505868.SGD","BK4585","LU0052756011.USD","LU2129689605.HKD","BK4534","LU0477156953.USD","LU0683600562.USD","LU0314106906.USD","IE0034235188.USD","LU1363072403.SGD","LU0256863902.USD","LU0310800965.SGD","LU0320765489.SGD","LU0477156797.USD","LU0320765646.SGD","LU1069347547.HKD","BK4539","BK4559","BK4611","RXRX","LU2129689514.USD","IE0002270589.USD","IE00BKVL7J92.USD","LU0098860793.USD","LU0306807586.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU0208291251.USD","LU0149725797.USD","LU0787776722.HKD","LU1074936037.SGD","LU1718418525.SGD","LU0170899867.USD","LU1883839398.USD","LU1201861165.SGD","LU0234572021.USD","LU1201861249.SGD","LU0130518102.USD","LU1506573853.SGD","LU1035773651.USD","LU1496350171.SGD","LU0203345920.USD","LU1880398554.USD","LU0130103400.USD"],"gpt_icon":0},{"id":"2614872069","title":"Cathie Wood’s ARK Investment buys 213K shares of Tempus AI today","url":"https://stock-news.laohu8.com/highlight/detail?id=2614872069","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614872069?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:10","pubTimestamp":1772068213,"startTime":"0","endTime":"0","summary":"20:06 EST Cathie Wood’s ARK Investment buys 213K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time, mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-213k-shares-of-tempus-ai-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-213k-shares-of-tempus-ai-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AIYY","BK4611","BK4588","BK4023","TEM","ARKK","BK4528","AI","BK4543","BK4551","BK4613","TEMT","BK4544","BK4121","LU1861558580.USD","BK4587","LU1861559042.SGD"],"gpt_icon":0},{"id":"2614639310","title":"Tempus AI Inc. Files Initial Beneficial Ownership Statement for Thomas Edward Schoenherr, CEO of Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614639310","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614639310?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:12","pubTimestamp":1772064765,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. filed an Initial Statement of Beneficial Ownership  naming Thomas Edward Schoenherr, CEO, Diagnostics, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL2kVfxH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","LU1861558580.USD","LU1861559042.SGD","BK4121","BK4611","BK4613","TEM"],"gpt_icon":1},{"id":"2614805310","title":"Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614805310?lang=en_us&edition=fundamental","pubTime":"2026-02-26 04:00","pubTimestamp":1772049624,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Recursion Pharmaceuticals (RXRX – Research Report) and Penumbra (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-recursion-pharmaceuticals-rxrx-and-penumbra-pen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-recursion-pharmaceuticals-rxrx-and-penumbra-pen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4082","BK4581","BK4609","LU0128526141.USD","BK4539","BK4585","BK4139","LU0029874061.USD","XBI","BK4588","LABU","PEN","BK4611","RXRX","BK4548"],"gpt_icon":0},{"id":"2614303929","title":"What's Behind The Jump In Recursion Pharmaceuticals Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614303929","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614303929?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:54","pubTimestamp":1772034840,"startTime":"0","endTime":"0","summary":"Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are surging Wednesday following a robust earnings report released before the bell.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Closse-up-Shot-Of-White-Pills-On-Conveyo.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Closse-up-Shot-Of-White-Pills-On-Conveyo.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50854848/whats-behind-the-jump-in-recursion-pharmaceuticals-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50854848/whats-behind-the-jump-in-recursion-pharmaceuticals-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4611","BK4539","BK4609","BK4139","RXRX","BK4548"],"gpt_icon":1},{"id":"2614033753","title":"Tempus AI Shares Fall 2.4% After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614033753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614033753?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:34","pubTimestamp":1772030076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4N3ZL1GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","TEM","BK4613","LU1861558580.USD","LU1861559042.SGD","BK4611","BK4121"],"gpt_icon":0},{"id":"2614336370","title":"Tempus AI price target raised to $68 from $59 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2614336370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614336370?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:19","pubTimestamp":1772029178,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Tempus AI (TEM) to $68 from $59 and keeps an Outperform rating on the shares. The firm updated its model fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-raised-to-68-from-59-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-raised-to-68-from-59-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIYY","AI","BK4587","BK4585","BK4588","BK4528","BK4121","TEMT","BK4023","LU1861558580.USD","BK4543","BK4611","BK4551","LU1861559042.SGD","BK4613","TEM"],"gpt_icon":0},{"id":"2614820300","title":"Tempus AI Inc (Pre-Reincorporation) : Btig Cuts Target Price to $90 From $105","url":"https://stock-news.laohu8.com/highlight/detail?id=2614820300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614820300?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:06","pubTimestamp":1772024764,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","TEM","BK4121","BK4613","BK4611","LU1861558580.USD","LU1861559042.SGD"],"gpt_icon":0},{"id":"2614082109","title":"Tempus AI price target lowered to $60 from $80 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082109","media":"TIPRANKS","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082109?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:56","pubTimestamp":1772024206,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Casey Woodring lowered the firm’s price target on Tempus AI (TEM) to $60 from $80 and keeps a Neutral rating on the shares post th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-60-from-80-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-60-from-80-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LU0868494708.USD","LU2023250504.SGD","LU2417539215.USD","LU2552382132.HKD","LU2505996509.AUD","LU1974910355.USD","BK4613","LU1917777945.USD","LU1032466523.USD","LU0265550359.USD","LU1988902786.USD","BK4550","LU0310799852.SGD","LU0942090050.USD","LU2381873111.SGD","IE0034235303.USD","BK4533","LU2462157665.USD","BK4581","LU0211326755.USD","AIYY","LU0345770308.USD","BK4587","LU2023250330.USD","LU0234572021.USD","LU1064131342.USD","LU1162221912.USD","IE000M9KFDE8.USD","LU2237443465.HKD","IE00BWXC8680.SGD","LU0170899867.USD","LU1548497426.USD","LU0971096721.USD","BK4585","LU0211327993.USD","LU0323591593.USD","BK4551","LU0868494617.USD","IE00BYXW3230.USD","IE00BHPRN162.USD","LU0267386448.USD","LU0820562030.AUD","LU0211328371.USD","LU1261432733.SGD","TEMT","AI","LU1670628061.USD","IE00B1BXHZ80.USD","JPM","LU1720051108.HKD","LU2213496289.HKD","IE00B3S45H60.SGD","LU2430703178.SGD","IE00BDRTCR15.USD","LU0070302665.USD","LU1363072403.SGD","LU1861559042.SGD","LU1668664300.SGD","IE00BBT3K403.USD","LU2357305700.SGD","LU0417517546.SGD","LU0320765646.SGD","LU2456880835.USD","IE0034235188.USD","LU2054465674.USD","LU0640476718.USD","LU0820561909.HKD","LU2236285917.USD","LU2242649171.HKD","LU1244550494.USD","LU0208291251.USD","LU2211815571.USD","BK4504","LU1551013425.SGD","BK4588","BK4516","LU1280957306.USD","IE00BJLML261.HKD","IE00BJTD4V19.USD","LU0689472784.USD","TEM","BK4207","LU2106854487.HKD","LU1496350502.SGD","LU0203345920.USD","LU1670627923.USD","IE00BKVL7J92.USD","LU1496350171.SGD","LU0149725797.USD","LU0006306889.USD","LU0964807845.USD","LU0976567544.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1894683348.USD","LU2023250843.SGD","LU0345769631.USD","LU2430703251.USD","LU1267930490.SGD","LU0215105999.USD","LU2756315664.SGD","LU2237443622.USD","LU2430703095.HKD","IE00BN8TJ469.HKD","LU2237443382.USD","LU2746668974.SGD","LU0683600562.USD","LU2237443978.SGD","LU1116320901.HKD","JPMO","LU0943347566.SGD","LU0106831901.USD","LU2505996681.GBP","LU2264538146.SGD","LU1914381329.SGD","LU1894683264.USD","LU2552382058.USD","LU1244550577.SGD","LU2756315318.SGD","BK4528","LU1084165304.USD","LU0265550946.USD","LU1720051017.SGD","LU0211326839.USD","LU1244550221.USD","LU2746668461.USD","BK4611","IE00BJTD4N35.SGD","LU1116320737.USD","LU2237443895.HKD","LU0251132253.USD","BK4023","LU0787776722.HKD","LU0238689110.USD","LU0211331839.USD","LU0882574139.USD","LU2237443549.SGD","IE00BDCRKT87.USD","IE00BLSP4239.USD","LU1119994496.HKD","BK4566","LU0106261372.USD","LU2552382215.SGD","IE0034235295.USD","IE00BKDWB100.SGD","LU0345770993.USD","LU1145028129.USD","IE00BZ1G4Q59.USD","BK4543","LU1861558580.USD","LU0820561818.USD","LU0256863811.USD","LU2592432038.USD","LU0496365809.HKD","LU0320765489.SGD","LU0048584097.USD","IE00BFXG1179.USD","LU0345769128.USD","BK4534","LU1366192091.USD","LU1629891620.HKD","LU1551013342.USD","SG9999002232.USD","LU0203347892.USD","IE00B1XK9C88.USD","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2614261082","title":"Tempus AI price target lowered to $70 from $76 at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2614261082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614261082?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:49","pubTimestamp":1772023775,"startTime":"0","endTime":"0","summary":"TD Cowen lowered the firm’s price target on Tempus AI (TEM) to $70 from $76 and keeps a Hold rating on the shares. The firm said its Q4 results were","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-70-from-76-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-70-from-76-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","BK4611","BK4207","BK4585","LU1861559042.SGD","BK4121","TEM","TEMT","LU1861558580.USD","BK4566","BK4127"],"gpt_icon":0},{"id":"2614966084","title":"Tempus AI Inc (Pre-Reincorporation) : Needham Cuts Target Price to $75 From $100","url":"https://stock-news.laohu8.com/highlight/detail?id=2614966084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614966084?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:36","pubTimestamp":1772022960,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4611","LU1861559042.SGD","BK4613","TEM","TEMT","LU1861558580.USD"],"gpt_icon":0},{"id":"2614089285","title":"Tempus AI Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089285","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089285?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:59","pubTimestamp":1772020740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2026 06:59 ET (11:59 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4613","LU1861559042.SGD","TEMT","LU1861558580.USD","BK4121","TEM"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":101,"code":"91000000","status":"200"}]}}